Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
Nakamura K, Miyoshi T, Yoshida M, Akagi S, Saito Y, Ejiri K, Matsuo N, Ichikawa K, Iwasaki K, Naito T, Namba Y, Yoshida M, Sugiyama H, Ito H.
Int J Mol Sci. 2022 Mar 25;23(7):3587. doi: 10.3390/ijms23073587.
Heart Failure in Type 2 Diabetes Mellitus.
Kenny HC, Abel ED.
Circ Res. 2019 Jan 4;124(1):121-141. doi: 10.1161/CIRCRESAHA.118.311371.
Diabetic Cardiomyopathy.
Dillmann WH.
Circ Res. 2019 Apr 12;124(8):1160-1162. doi: 10.1161/CIRCRESAHA.118.314665.
NR4A3 prevents diabetes induced atrial cardiomyopathy by maintaining mitochondrial energy metabolism and reducing oxidative stress.
Peng H, Yuan J, Wang Z, Mo B, Wang Y, Wang Y, Wang Q.
EBioMedicine. 2024 Aug;106:105268. doi: 10.1016/j.ebiom.2024.105268. Epub 2024 Aug 3.
Heart failure in diabetes.
Jankauskas SS, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A, Gambardella J, Santulli G.
Metabolism. 2021 Dec;125:154910. doi: 10.1016/j.metabol.2021.154910. Epub 2021 Oct 8.
Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus.
Graczyk P, Dach A, Dyrka K, Pawlik A.
Int J Mol Sci. 2024 May 5;25(9):5027. doi: 10.3390/ijms25095027.
Molecular mechanisms of diabetic cardiomyopathy.
Bugger H, Abel ED.
Diabetologia. 2014 Apr;57(4):660-71. doi: 10.1007/s00125-014-3171-6. Epub 2014 Jan 30.
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Jia G, DeMarco VG, Sowers JR.
Nat Rev Endocrinol. 2016 Mar;12(3):144-53. doi: 10.1038/nrendo.2015.216. Epub 2015 Dec 18.
Diabetic cardiomyopathy.
Lorenzo-Almorós A, Cepeda-Rodrigo JM, Lorenzo Ó.
Rev Clin Esp (Barc). 2022 Feb;222(2):100-111. doi: 10.1016/j.rceng.2019.10.012. Epub 2020 Oct 23.
From Type 2 Diabetes Mellitus To Diabetic Cardiomyopathy - A Systematic Review On The Role Of MicroRNA.
Żarek-Starzewska A, Klimczak-Tomaniak D, Mądrecka A, Sygitowicz G, Janiszewski M, Kuch M.
Curr Diab Rep. 2025 Jul 15;25(1):42. doi: 10.1007/s11892-025-01590-6.
